Well CWN's metrics for q1 were poor. I suspect this will impact on SGR a bit up until the AGM, on top of the other stuff.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025